EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

6p21.3 microdeletion involving the SYNGAP1 gene in a patient with intellectual disability, seizures, and severe speech impairment



6p21.3 microdeletion involving the SYNGAP1 gene in a patient with intellectual disability, seizures, and severe speech impairment



American Journal of Medical Genetics. Part A 161a(7): 1682-1685



The chromosome 6p21.3 microdeletion phenotype was recently identified through array comparative genomic hybridization. The main features are developmental delay with severe speech impairment, seizures, and behavioral abnormalities. Three patients have been reported with deletion sizes ranging from 100 to 800 kb. We report on a 9-year-old boy with an apparently de novo, 50 kb deletion, and global developmental delay, severe speech impairment, and generalized epilepsy well-controlled by medication. There were four genes identified in this deletion, of which SYNGAP1 is considered to be responsible for speech impairment and epilepsy. We compared the clinical features of this patient with previously reported patients with 6p21.3 and patients with SYNGAP1 mutations. © 2013 Wiley Periodicals, Inc.

(PDF emailed within 0-6 h: $19.90)

Accession: 051051647

Download citation: RISBibTeXText

PMID: 23687080

DOI: 10.1002/ajmg.a.35930



Related references

A balanced translocation disrupts SYNGAP1 in a patient with intellectual disability, speech impairment, and epilepsy with myoclonic absences (EMA). Epilepsia 52(12): E190-E193, 2012

3p14.1 de novo microdeletion involving the FOXP1 gene in an adult patient with autism, severe speech delay and deficit of motor coordination. Gene 516(1): 107-113, 2013

A New 3p14.2 Microdeletion in a Patient with Intellectual Disability and Language Impairment: Case Report and Review of the Literature. Molecular Syndromology 9(4): 175-181, 2018

Refinement of the critical region of 1q41q42 microdeletion syndrome identifies FBXO28 as a candidate causative gene for intellectual disability and seizures. American Journal of Medical Genetics. Part A 164a(2): 441-448, 2014

De Novo Mutations in CHAMP1 Cause Intellectual Disability with Severe Speech Impairment. American Journal of Human Genetics 97(3): 493-500, 2015

3p14 De Novo Interstitial Microdeletion in a Patient with Intellectual Disability and Autistic Features with Language Impairment: A Comparison with Similar Cases. Case Reports in Genetics 2015: 876348-876348, 2015

A novel SYNGAP1 variant in a patient with intellectual disability and distinctive dysmorphisms. Congenital Anomalies, 2018

RORB gene and 9q21.13 microdeletion: report on a patient with epilepsy and mild intellectual disability. European Journal of Medical Genetics 57(1): 44-46, 2014

Mutations affecting the SAND domain of DEAF1 cause intellectual disability with severe speech impairment and behavioral problems. American Journal of Human Genetics 94(5): 649-661, 2014

Absence seizures with intellectual disability as a phenotype of the 15q13.3 microdeletion syndrome. Epilepsia 52(12): E194-E198, 2012

UBE2A deficiency syndrome: Mild to severe intellectual disability accompanied by seizures, absent speech, urogenital, and skin anomalies in male patients. American Journal of Medical Genetics. Part A 152a(12): 3084-3090, 2011

De novo triplication of the MAPT gene from the recurrent 17q21.31 microdeletion region in a patient with moderate intellectual disability and various minor anomalies. American Journal of Medical Genetics. Part A 158a(7): 1765-1770, 2012

Microdeletion of 12q24.31: report of a girl with intellectual disability, stereotypies, seizures and facial dysmorphisms. American Journal of Medical Genetics. Part A 167a(2): 438-444, 2015

Molecular characterization of 1q44 microdeletion in 11 patients reveals three candidate genes for intellectual disability and seizures. American Journal of Medical Genetics. Part A 158a(7): 1633-1640, 2012

16p11.2 de novo microdeletion encompassing SRCAP gene in a patient with speech impairment, global developmental delay and behavioural problems. European Journal of Medical Genetics 57(11-12): 649-653, 2015